XML 22 R8.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statement of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net loss: $ (10,638) $ (8,786) $ (11,878)
Adjustments required to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation 3,436 3,046 2,887
Amortization of intangible assets 833 1,090 1,996
Equity-based compensation 19,796 15,575 16,198
Realized gain, net on sale of available-for-sale marketable securities (56) (14) (90)
Amortization of discounts on available-for-sale marketable securities (755) (922) (124)
Unrealized foreign exchange (gain) loss, net (1,029) 1,108 (560)
Gain on sale of Intrinsix (0) (0) 11,557
Remeasurement of marketable equity securities 257 94 2
Changes in operating assets and liabilities:      
Trade receivables, net (11,846) (6,777) (25)
Prepaid expenses and other assets 281 (4,751) (4,850)
Operating lease right-of-use assets (11,675) 1,167 3,305
Accrued interest on bank deposits (23) 527 (237)
Deferred taxes, net 1,055 (68) 6,684
Trade payables 552 (261) (818)
Deferred revenues (103) 581 (27)
Accrued expenses and other payables (890) 477 (182)
Accrued payroll and related benefits (1,987) 2,664 (3,737)
Operating lease liability 10,226 (810) (3,273)
Income taxes payable (706) (221) 67
Accrued severance pay, net (84) (248) (112)
Net cash provided by (used in) operating activities (3,356) 3,471 (6,331)
Cash flows from investing activities:      
Business combination (0) (0) 3,600
Purchase of property and equipment 2,921 2,955 2,884
Proceeds from the sale of Intrinsix, net 3,470 540 30,589
Investment in bank deposits 2,705 2,000 2,000
Proceeds from bank deposits 2,000 10,000 6,000
Investment in available-for-sale marketable securities 106,440 46,864 40,026
Proceeds from maturity of available-for-sale marketable securities 61,297 29,780 10,340
Proceeds from sale of available-for-sale marketable securities 11,301 9,806 12,417
Net cash provided by (used in) investing activities (33,998) (2,446) 10,836
Cash flows from financing activities:      
Purchase of treasury stock (7,150) (8,456) (6,163)
Proceeds from issuance of common stock, net of issuance costs 63,261 0 0
Proceeds from exercise of stock-based awards 3,224 2,883 3,393
Net cash provided by (used in) financing activities 59,335 (5,573) (2,770)
Effect of exchange rate changes on cash and cash equivalents      
Effect of exchange rate changes on cash and cash equivalents 107 (241) 267
Increase (decrease) in cash and cash equivalents 22,088 (4,789) 2,002
Cash and cash equivalents at the beginning of the year 18,498 23,287 21,285
Cash and cash equivalents at the end of the year 40,586 18,498 23,287
Supplemental information of cash-flows activities:      
Income and withholding taxes 4,182 6,261 7,398
Non-cash transactions:      
Transaction costs related to the Intrinsix but unpaid at the end of the year 0 0 25
Property and equipment purchases incurred but unpaid at the end of the year 692 215 0
Right-of-use assets obtained in the exchange for operating lease liabilities 14,084 1,324 1,100
Reconciliation of cash and cash equivalents as shown in the condensed consolidated statements of cash flow:      
Cash and cash equivalents in the Consolidated Balance Sheets 40,586 18,498 23,287
Cash and cash equivalents included in assets of discontinued operation 0 0 0
Total cash and cash equivalents in the Consolidated Statements of Cash Flows 40,586 18,498 23,287
Ceva Technologies Single Member Private Company [Member]      
Cash flows from investing activities:      
Asset acquisition $ 0 $ (753) $ 0